CAS 2024548-03-4

Lin28-let-7a antagonist 1

CAS: 2024548-03-4

Lin28-let-7a antagonist 1

Fórmula: C₃₁H₂₉N₅O₇

Pureza: ≥98%

Peso molecular: 583.59

Ref: 54-BUP05444

4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid

CAS: 2024548-03-4

4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid

Fórmula: C₃₁H₂₉N₅O₇

Pureza: 99%

Peso molecular: 583.59

Ref: 54-OR1023977

Lin28-let-7a antagonist 1

CAS: 2024548-03-4

Lin28-let-7a antagonist 1, with an IC50 of 4.03 μM for Lin28A-let-7a-1 interaction，and shows a clear antagonistic effect against the Lin28-let-7a interaction.

Fórmula: C₃₁H₂₉N₅O₇

Pureza: 99.44%

Cor e Forma: Solid

Peso molecular: 583.59

Ref: TM-T11851

Lin28-let-7a antagonist 1

CAS: 2024548-03-4

Fórmula: C₃₁H₂₉N₅O₇

Pureza: 99%

Peso molecular: 583.5913

Ref: IN-DA01JQUC

Lin28-let-7a antagonist 1

CAS: 2024548-03-4

4-(7-(4-((Benzyloxy)carbonyl)piperazin-1-yl)-4,4-dimethyl-8-nitrochromeno[4,3-c]pyrazol-1(4H)-yl)benzoic acid

Fórmula: C₃₁H₂₉N₅O₇

Pureza: 99%

Peso molecular: 583.59

Ref: IN-DG00800795

Lin28-let-7a antagonist 1

CAS: 2024548-03-4

Lin28-let-7a antagonist 1 is a small molecule inhibitor, which is a chemically synthesized compound with significant therapeutic potential. It acts by targeting the Lin28/let-7 axis, a critical regulatory pathway involved in cellular processes such as development, metabolism, and tumorigenesis. The source of this antagonist is a synthetic, rationally designed compound, optimized for high specificity and potency.

Fórmula: C₃₁H₂₉N₅O₇

Pureza: Min. 95%

Peso molecular: 583.59 g/mol

Ref: 3D-ZFD54803